A strategy for tackling antimicrobial resistance: It’s more than a prescribing problem

Abstract

Get full access to this article

View all access options for this article.

References

Barbosa

Levy

. (2000) The impact of antibiotic use on resistance development and persistence. Drug Resistance Updates 3: 303–311.

Cafazzo

St-Cyr

. (2012) From discovery to design: the evolution of human factors in healthcare. Healthcare Quarterly 15: 24–29.

Duerdin

Fry

Johnson

Wilcox

. (2015) The control of methicillin resistant Staphylococcus aureus blood stream infections in England. Open Forum Infectious Diseases 2: ofv035.

Global & Public Health Group. (2019) Contained and controlled: the UK’s 20-year vision for antimicrobial resistance. London: HM Government. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773065/uk-20-year-vision-for-antimicrobial-resistance.pdf.

Global & Public Health Group. (2019) Tackling antimicrobial resistance 2019–2024: The UK’s five-year national action plan. London: HM Government. Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/773130/uk-amr-5-year-national-action-plan.pdf.

World Health Organization. (2018) Improving infection prevention and control at the health facility: Interim practical manual supporting implementation of the WHO Guidelines on Core Components of Infection Prevention and Control Programmes. Geneva: WHO. Available at: https://www.who.int/infection-prevention/tools/core-components/facility-manual.pdf.

Wilson

. (2018) Applying Pareto analysis to reducing Escherichia coli bloodstream infections. Journal of Infection Prevention 19: 208–210.